Search

Your search keyword '"recurrent hepatocellular carcinoma"' showing total 870 results

Search Constraints

Start Over You searched for: Descriptor "recurrent hepatocellular carcinoma" Remove constraint Descriptor: "recurrent hepatocellular carcinoma"
870 results on '"recurrent hepatocellular carcinoma"'

Search Results

201. Multimodal treatment modalities are associated with improved long-term outcome in patients with recurrent hepatocellular carcinoma

202. Surveillance Strategy after Complete Ablation of Initial Recurrent Hepatocellular Carcinoma: A Risk-Based Machine Learning Study

203. A Machine-learning Algorithm to Select the Best Potential Treatment Providing the Longer Survival for Recurrent Hepatocellular Carcinoma: An Italian Multicentric Proposal

204. Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation.

205. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma -- A systematic review.

206. Stereotactic Body Radiation Therapy in Recurrent Hepatocellular Carcinoma

207. Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation

208. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas.

209. Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy

210. Radiofrequency ablation prior to liver transplantation: focus on complications and on a rare but severe case.

211. Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma

212. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent‐to‐treat analysis

213. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery

214. ACR Appropriateness Criteria ® Chronic Liver Disease

215. Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection

216. Treatment for intrahepatic recurrence after curative resection of hepatocellular carcinoma: Salvage liver transplantation or re-resection/radiofrequency ablation? A Retrospective Cohort Study

217. Laparoscopic Total Caudate Lobectomy for Hepatocellular Carcinoma

218. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria

219. The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation

220. Recurrent Hepatocellular Carcinoma in the Right Adrenal Gland 11 Years After Liver Transplantation for Hepatocellular Carcinoma: a Case Report and Literature Review

221. Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation

222. Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma

223. Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry

224. Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma

225. Survival following redo hepatectomy vs radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis

226. Effectiveness of Radiofrequency Ablation of Initial Recurrent Hepatocellular Carcinoma after Hepatectomy: Long-Term Results and Prognostic Factors

227. Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence

229. Positron Emission Tomography Scan in Detecting and Locating Extrahepatic Recurrent Hepatocellular Carcinoma Post Orthotic Liver Transplant

230. Spiral computed tomography versus ultrasound in the follow-up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study

231. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer.

232. Recurrent hepatocellular carcinoma in pregnancy: A case report and literature review

233. Natural history of liver adenomatosis: A long-term observational study

234. Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation

235. Perioperative outcomes comparing laparoscopic with open repeat liver resection for post-hepatectomy recurrent liver cancer: A systematic review and meta-analysis

236. Options for the treatment of intrahepatic recurrent hepatocellular carcinoma: Salvage liver transplantation or rehepatectomy?

237. Regorafenib Combined With Sirolimus Achieves Successful Treatment of Diffuse Double Lung Metastasis After Liver Transplantation in Giant Liver Cancer Beyond Transplantation Criteria: A Case Report

238. Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α

239. Hypofractionated radiotherapy as a salvage treatment for recurrent hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multi-center analysis

240. Recurrence After Curative Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: Diagnostic Algorithms on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging

241. IDDF2019-ABS-0094 Tumor size and location affecting the treatment selection for solitary small recurrent hepatocellular carcinoma (≤3.0 cm) after initial hepatectomy

242. IDDF2019-ABS-0063 A difference-in-difference based CT radiomics algorithm for detecting recurrence of hepatocellular carcinoma after resection or ablation: an exploratory analysis

243. IDDF2019-ABS-0082 Microvascular invasion at primary resection guiding the therapeutic options of recurrent intermediate-advanced hepatocellular carcinoma

244. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma

245. Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival

246. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection

247. Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection

248. Our experience of repeat laparoscopic liver resection in patients with recurrent hepatocellular carcinoma

249. Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI

250. Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular Carcinoma

Catalog

Books, media, physical & digital resources